It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 02423cam 2200565 a 4500
001 ocm20898156
003 OCoLC
005 20201202175513.0
008 891019s1988 enka b 100 0 eng
040 $aNLM$beng$cNLM$dUKM$dCGC$dTPH$dOCLCF$dOCLCQ$dNLM$dOCLCO$dOCLCA
015 $aGB8842560$2bnb
016 7 $a8916677$2DNLM
019 $a18323744$a1027319245$a1119414492
020 $a9780905958804$q(pbk.)
020 $a0905958802$q(pbk.)
035 $a(OCoLC)20898156$z(OCoLC)18323744$z(OCoLC)1027319245$z(OCoLC)1119414492
050 14 $aRL151
060 00 $aW3$bIN207 no.132 1988
060 10 $aWR 415$bS443 1987
082 04 $a616.5/46$a616.97/3$219
245 00 $aSeborrhoeic dermatitis and dandruff :$ba fungal disease /$cedited by Sam Shuster, Nigel Blatchford.
260 $aLondon ;$aNew York :$bRoyal Society of Medicine Services,$c1988.
300 $avii, 54 pages :$billustrations.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aInternational congress and symposium series ;$vno. 132
500 $aProceedings of a meeting sponsored by Janssen Pharmaceutical Ltd. and held at the Royal Society of Medicine, London, Dec. 17, 1987.
504 $aIncludes bibliographical references.
650 0 $aHair$xDiseases$vCongresses.
650 0 $aScalp$xDiseases$vCongresses.
650 0 $aDandruff$vCongresses.
650 7 $aDandruff.$2fast$0(OCoLC)fst00887614
650 7 $aHair$xDiseases.$2fast$0(OCoLC)fst00950366
650 7 $aScalp$xDiseases.$2fast$0(OCoLC)fst01106354
650 2 $aDermatitis, Seborrheic$xdrug therapy.
650 2 $aKetoconazole.
650 2 $aMalassezia$xdrug effects.
650 2 $aMalassezia$xpathogenicity.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 2 $aCongress.
700 1 $aShuster, Sam.
700 1 $aBlatchford, Nigel.
710 2 $aJanssen Pharmaceutical Ltd.
776 08 $iOnline version:$tSeborrhoeic dermatitis and dandruff.$dLondon ; New York : Royal Society of Medicine Services, 1988$w(OCoLC)575452725
776 08 $iOnline version:$tSeborrhoeic dermatitis and dandruff.$dLondon ; New York : Royal Society of Medicine Services, 1988$w(OCoLC)608572618
830 0 $aInternational congress and symposium series ;$vno. 132.
029 0 $aNLM$b8916677
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 36 OTHER HOLDINGS